Tan Yang
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Biotechnology top 2%
- Cancer Research and Treatments
Papers in
-
- Nanoplatforms for cancer theranostics 16
- Biomaterials 11
- Nanoparticle-Based Drug Delivery 11
- Co-authors
- Guangya Xiang (16 shared papers)Chuanchuan He (12 shared papers)Xiang Ma (10 shared papers)Ruicong Yan (9 shared papers)Xiaojuan Zhang (10 shared papers)Richard M. Hoffman (4 shared papers)Yao Lu (9 shared papers)Pengxuan Zhao (8 shared papers)
- Journals
- International Journal of Pharmaceutics (3 papers)Acta Pharmaceutica Sinica B (2 papers)Theranostics (2 papers)Pharmaceutics (2 papers)Acta Biomaterialia (2 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Tan Yang
34 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 99
- Biomaterials 466
- Biotechnology 291
- Molecular Medicine 93
- Biochemistry 108
- Cancer Research 204
Countries citing papers authored by Tan Yang
This map shows the geographic impact of Tan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tan Yang more than expected).
Fields of papers citing papers by Tan Yang
This network shows the impact of papers produced by Tan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tan Yang. The network helps show where Tan Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Tan Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 133 | |
| 2 | Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice. | 1999 | 113 |
| 3 | Synergy between methionine stress and chemotherapy in the treatment of brain tumor xenografts in athymic mice. | 2001 | 104 |
| 4 | 2021 | 98 | |
| 5 | 2014 | 83 | |
| 6 | 2019 | 81 | |
| 7 | 2014 | 72 | |
| 8 | 2021 | 70 | |
| 9 | Serum methionine depletion without side effects by methioninase in metastatic breast cancer patients. | 1997 | 70 |
| 10 | 2018 | 60 | |
| 11 | Anticancer efficacy of methioninase in vivo. | 1997 | 59 |
| 12 | 2019 | 55 | |
| 13 | 2018 | 53 | |
| 14 | 2019 | 41 | |
| 15 | 2020 | 36 | |
| 16 | IL-2 gene therapy of advanced lung cancer patients. | 1996 | 31 |
| 17 | 2024 | 29 | |
| 18 | 2019 | 29 | |
| 19 | 2020 | 27 | |
| 20 | 2018 | 27 |
About Tan Yang
Tan Yang is a scholar working on Biomedical Engineering, Biomaterials, Cancer Research, Molecular Biology and Oncology, having authored 37 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (16 papers), Nanoparticle-Based Drug Delivery (11 papers), Cancer, Hypoxia, and Metabolism (7 papers), Cancer Research and Treatments (6 papers), RNA Interference and Gene Delivery (5 papers), Advanced Nanomaterials in Catalysis (5 papers), Photodynamic Therapy Research Studies (4 papers) and Luminescence and Fluorescent Materials (3 papers). The work is most often cited by research in Biomaterials (466 citations), Biotechnology (291 citations), Molecular Medicine (93 citations), Biochemistry (108 citations) and Cancer Research (204 citations). Tan Yang has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Guangya Xiang, Chuanchuan He, Xiang Ma, Ruicong Yan, Xiaojuan Zhang, Richard M. Hoffman, Yao Lu, Pengxuan Zhao, Ting Fan and Yan Chen. Their work appears in journals such as International Journal of Pharmaceutics, Acta Pharmaceutica Sinica B, Theranostics, Pharmaceutics and Acta Biomaterialia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.